ATE328613T1 - Modifizierte therapeutische mittel - Google Patents

Modifizierte therapeutische mittel

Info

Publication number: ATE328613T1
Authority: AT; Austria
Prior art keywords: elements; agent; modified therapeutic; therapeutic agents; modified
Prior art date: 2002-09-05

Application number

AT03793901T

Other languages

English (en)

Inventor

Dirk Esser

Jason Richard Betley

Simon Hugh Ridley

Original Assignee

Adprotech Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-09-05

Filing date

2003-09-05

Publication date

2006-06-15

2003-09-05 Application filed by Adprotech Ltd filed Critical Adprotech Ltd

2006-06-15 Application granted granted Critical

2006-06-15 Publication of ATE328613T1 publication Critical patent/ATE328613T1/de

Links

239000003814 drug Substances 0.000 title abstract 2
229940124597 therapeutic agent Drugs 0.000 title abstract 2
239000012528 membrane Substances 0.000 abstract 3
239000003795 chemical substances by application Substances 0.000 abstract 2
125000002252 acyl group Chemical group 0.000 abstract 1
125000001931 aliphatic group Chemical group 0.000 abstract 1
239000000823 artificial membrane Substances 0.000 abstract 1
230000001413 cellular effect Effects 0.000 abstract 1
125000003074 decanoyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C(*)=O 0.000 abstract 1
210000003722 extracellular fluid Anatomy 0.000 abstract 1
125000003104 hexanoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 abstract 1
125000001419 myristoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Biochemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Veterinary Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Vascular Medicine (AREA)
Urology & Nephrology (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Steroid Compounds (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

AT03793901T 2002-09-05 2003-09-05 Modifizierte therapeutische mittel ATE328613T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB0220936.9A GB0220936D0 (en)	2002-09-05	2002-09-05	Modified therapeutic agents

Publications (1)

Publication Number	Publication Date
ATE328613T1 true ATE328613T1 (de)	2006-06-15

Family

ID=9943766

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT03793901T ATE328613T1 (de)	2002-09-05	2003-09-05	Modifizierte therapeutische mittel

Country Status (8)

Country	Link
US (2)	US20060241048A1 (de)
EP (1)	EP1542730B1 (de)
AT (1)	ATE328613T1 (de)
AU (1)	AU2003260791A1 (de)
CA (1)	CA2536795A1 (de)
DE (1)	DE60305940T2 (de)
GB (1)	GB0220936D0 (de)
WO (1)	WO2004022101A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9614871D0 (en) *	1996-07-15	1996-09-04	Smithkline Beecham Plc	Compounds
GB0220936D0 (en) *	2002-09-05	2002-10-23	Adprotech Ltd	Modified therapeutic agents
GB0915519D0 (en)	2009-09-04	2009-10-07	King S College London	Ntithrombotic compounds
GB201402267D0 (en) *	2014-02-10	2014-03-26	Cambridge Entpr Ltd	Antibacterial agents
GB202002707D0 (en) *	2020-02-26	2020-04-08	King S College London	Compositions and methods
WO2022032140A2 (en) *	2020-08-07	2022-02-10	Amicus Therapeutics, Inc.	Vesicle targeting proteins and uses of same

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5169933A (en)	1988-08-15	1992-12-08	Neorx Corporation	Covalently-linked complexes and methods for enhanced cytotoxicity and imaging
WO1993022343A1 (en)	1992-05-01	1993-11-11	The Rockfeller University	Multiple antigen peptide system having adjuvant properties and vaccines prepared therefrom
US5716614A (en)	1994-08-05	1998-02-10	Molecular/Structural Biotechnologies, Inc.	Method for delivering active agents to mammalian brains in a complex with eicosapentaenoic acid or docosahexaenoic acid-conjugated polycationic carrier
GB9614871D0 (en) *	1996-07-15	1996-09-04	Smithkline Beecham Plc	Compounds
GB9704519D0 (en) *	1997-03-05	1997-04-23	Smithkline Beecham Plc	Compounds
US7081495B1 (en)	1998-09-23	2006-07-25	School Of Pharmacy, University Of London	Cationic compounds and their use as macro molecular carriers
GB0026924D0 (en)	2000-11-03	2000-12-20	Univ Cambridge Tech	Antibacterial agents
GB0220936D0 (en)	2002-09-05	2002-10-23	Adprotech Ltd	Modified therapeutic agents

2002
- 2002-09-05 GB GBGB0220936.9A patent/GB0220936D0/en not_active Ceased
2003
- 2003-09-05 EP EP03793901A patent/EP1542730B1/de not_active Expired - Lifetime
- 2003-09-05 AT AT03793901T patent/ATE328613T1/de not_active IP Right Cessation
- 2003-09-05 WO PCT/GB2003/003867 patent/WO2004022101A1/en not_active Ceased
- 2003-09-05 AU AU2003260791A patent/AU2003260791A1/en not_active Abandoned
- 2003-09-05 DE DE60305940T patent/DE60305940T2/de not_active Expired - Lifetime
- 2003-09-05 CA CA002536795A patent/CA2536795A1/en not_active Abandoned
- 2003-09-05 US US10/526,808 patent/US20060241048A1/en not_active Abandoned
2010
- 2010-01-15 US US12/688,252 patent/US8455447B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
DE60305940T2 (de)	2007-02-01
US8455447B2 (en)	2013-06-04
CA2536795A1 (en)	2004-03-18
EP1542730B1 (de)	2006-06-07
EP1542730A1 (de)	2005-06-22
WO2004022101A1 (en)	2004-03-18
US20060241048A1 (en)	2006-10-26
DE60305940D1 (de)	2006-07-20
US20110086808A1 (en)	2011-04-14
AU2003260791A1 (en)	2004-03-29
GB0220936D0 (en)	2002-10-23

Similar Documents

Publication	Publication Date	Title
NO20044039L (no)	2004-09-29	Konjugatorer av terapeutiske eller cytotoksiske midler og biologisk aktive peptider.
DK1097173T3 (da)	2008-09-01	Anvendelse af peptider af IL-2 og derivater deraf som terapeutiske midler
BRPI0718688A8 (pt)	2022-08-30	Composições de baixa irritação e métodos para preparar as mesmas
ECSP088508A (es)	2008-07-30	Antagonistas de neuropilina
ATE350409T1 (de)	2007-01-15	Ampholytisches copolymer und dessen verwendung
CY1116169T1 (el)	2017-02-08	Συνθεσεις και μεθοδοι χρησης πεπτιδιων προνησιδιων και αναλογων εξ' αυτων
BRPI0809583A2 (pt)	2019-09-03	polipeptídeos fgf-21 modificados e seus usos
BRPI0507118A (pt)	2007-06-19	polipeptìdeos de interferon humano modificado e seus usos
FR2874011B1 (fr)	2007-06-15	Derives de sulfonamides, leur preparation et leur application en therapeutique
BR0107691A (pt)	2005-03-22	Sapogeninas substituìdas e seu uso
DK1792927T3 (da)	2013-06-10	Ny blokcopolymer, micelletilberedning og anticancermiddel indeholdende samme som aktiv ingrediens
NI200600290A (es)	2007-08-07	Derivados de pirazol, composiciones que contienen dichos compuestos y procedimientos de uso
FR2864958B1 (fr)	2006-02-24	Derive de n-[(1,5-diphenyl-1h-pyrazol-3-yl)methyl] sulfonamide, leur preparation et leur application en therapeutique.
CY1112682T1 (el)	2016-02-10	Ενεργες παραλλαγες της πρωτεϊνης προσδεσης il-18 και ιατρικες χρησεις αυτων
DK1469843T3 (da)	2007-11-05	Komposition til farmaceutisk eller diætetisk anvendelse til at bekæmpe hårtab
PT1228028E (pt)	2005-10-31	Sais de hidroxieicosatetraeniato, composicoes e metodos para utilizacao no tratamento de perturbacoes da secura ocular
NO20062709L (no)	2006-08-11	Stamceller som er egnet for transplantasjon, fremstilling derav og farmasoytiske preperater omfattende nevnte stamceller
ATE328613T1 (de)	2006-06-15	Modifizierte therapeutische mittel
DK1228097T3 (da)	2006-04-18	Antimikrobiel aktivitet af den förste kationiske humane lactoferrin-klynge
ITRM20030363A1 (it)	2005-01-25	Composizioni comprendenti la 3, 5diiodotironina e uso farmaceutico di esse.
PT1282418E (pt)	2005-10-31	Utilizacao de derivados pirazolo para o tratamento da infertilidade
EP2332526A3 (de)	2011-10-12	Kombination eines Renin-Inhibitors mit einem anti-dyslipidämischen Wirkstoff oder einem Wirkstoff gegen Adipositas
FR2870846B1 (fr)	2006-08-04	Derives de tetrahydroisoquinolylsulfonamides, leur preparation et leur utilisation en therapeutique
FR2806722B1 (fr)	2002-05-17	Derives de n-(heterocyclylbutyl) benzene-ou pyridine sulfonamide, leur preparation et leur application en therapeutique
ATE348886T1 (de)	2007-01-15	Auf zelluläre ziele gerichtete verbindungen

Legal Events

Date

Code

Title

Description

2007-05-15

UEP

Publication of translation of european patent specification

Ref document number: 1542730

Country of ref document: EP

2011-06-15

REN

Ceased due to non-payment of the annual fee